InspireMD, Inc. (NSPR)

↓ Download CSV

CIK 0001433607 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, InspireMD, Inc. reported revenue of $8.98M, up 28.1% from the prior year. The company ran a net loss, with a net margin of -543.3% and a gross margin of 29.5%. It held $69.40M in total assets against $14.20M in total liabilities.

Key ratios (FY2025)

29.5%
Gross margin
-552.6%
Operating margin
-543.3%
Net margin
-88.4%
Return on equity
+28.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$8.98M$7.01M$6.21M$5.17M$4.50M$2.48M$3.72M$3.60M$2.76M
Cost of Revenue$6.33M$5.50M$4.40M$4.05M$3.74M$2.40M$2.96M$2.61M$2.18M$1.79M
Gross Profit$2.65M$1.51M$1.81M$1.12M$754.0K$83.0K$756.0K$995.0K$585.0K$102.0K
Operating Income-$49.61M-$33.50M-$21.14M-$18.71M-$14.72M-$10.38M-$9.82M-$7.61M-$8.23M-$7.65M
Net Income-$48.79M-$32.01M-$19.92M-$18.49M-$14.92M-$10.54M-$10.04M-$7.24M-$8.44M-$8.46M
EPS (Diluted)$-0.76$-0.76$-0.82$-2.35$-2.03
Total Assets$69.40M$46.81M$47.64M$24.65M$39.71M$17.78M$9.88M$12.29M$6.11M$9.41M
Total Liabilities$14.20M$10.72M$8.14M$7.26M$6.18M$5.61M$4.50M$3.52M$3.11M$5.37M
Shareholders' Equity$55.20M$36.09M$39.50M$17.39M$33.53M$12.16M$5.38M$8.76M$2.73M$4.04M
Cash & Equivalents$8.94M$18.92M$9.64M$4.63M$12.00M$12.64M$5.51M$9.38M$3.71M$7.52M
Operating Cash Flow-$35.10M-$21.87M-$16.38M-$15.54M-$13.21M-$9.08M-$9.81M-$7.61M-$8.13M
Capital Expenditures$1.66M$1.40M$381.0K$473.0K$344.0K$88.0K$284.0K$67.0K$258.0K$49.0K
Shares Outstanding43.53M26.61M21.84M8.33M8.30M3.28M3.92M38.40M1.48M42.7K